Background
Methods
Setting
Design
Event eligibility
Infection and resistance definitions
Statistical methods
Results
SSI events and patients
CSEC (N = 141) | COLO (N = 22) | CBGB (N = 153) | CHOL (N = 19) | HER (N = 16) | KPRO (N = 19) | Others (N = 33) | Total (N = 403) | |
---|---|---|---|---|---|---|---|---|
Eligibility | ||||||||
Procedures surveyeda | 12,002 (53.9%) | 181 (0.8%) | 2409 (10.8%) | 2696 (12.1%) | 1613 (7.3%) | 1312 (5.9%) | 2035 (9.1%) | 22,248 (100.0%) |
SSI events detecteda | 232 (38.5%) | 28 (4.7%) | 208 (34.6%) | 29 (4.8%) | 31 (5.1%) | 31 (5.1%) | 43 (7.1%) | 602 (100.0%) |
SSI proportion | 232 (1.9%) | 28 (15.5%) | 208 (8.6%) | 29 (1.1%) | 31 (1.9%) | 31 (2.4%) | 43 (2.1%) | 602 (2.7%) |
Included procedures | 141 (60.8%) | 22 (78.6%) | 153 (73.6%) | 19 (65.5%) | 16 (51.6%) | 19 (61.3%) | 33 (76.7%) | 403 (66.9%) |
Included specimensa | 160 (32.5%) | 29 (5.9%) | 194 (39.4%) | 28 (5.7%) | 21 (4.3%) | 22 (4.5%) | 38 (7.7%) | 492 (100.0%) |
Hospital facilitya | ||||||||
KAMC-Riyadh | 9 (5.0%) | 22 (12.3%) | 131 (73.2%) | 1 (0.6%) | 3 (1.7%) | 1 (0.6%) | 12 (6.7%) | 179 (100.0%) |
KAMC-Jeddah | 76 (51.4%) | 0 (0.0%) | 22 (14.9%) | 13 (8.8%) | 10 (6.8%) | 13 (8.8%) | 14 (9.5%) | 148 (100.0%) |
KAH-Al hasa | 15 (75.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 5 (25.0%) | 20 (100.0%) |
IAFH-Dammam | 41 (73.2%) | 0 (0.0%) | 0 (0.0%) | 5 (8.9%) | 3 (5.4%) | 5 (8.9%) | 2 (3.6%) | 56 (100.0%) |
Age, mean ± SDb | 31.2 ± 6.5 | 52.1 ± 18.0 | 63.9 ± 8.7 | 49.2 ± 15.1 | 51.0 ± 16.1 | 64.7 ± 11.4 | 50.9 ± 19.4 | 49.5 ± 18.0 |
Genderb | ||||||||
Male | 0 (0.0%) | 12 (54.5%) | 78 (52.0%) | 5 (26.3%) | 4 (25.0%) | 8 (42.1%) | 13 (39.4%) | 120 (30.0%) |
Female | 141 (100.0%) | 10 (45.5%) | 72 (48.0%) | 14 (73.7%) | 12 (75.0%) | 11 (57.9%) | 20 (60.6%) | 280 (70.0%) |
Admission | ||||||||
ICU | 3 (2.1%) | 6 (27.3%) | 153 (100.0%) | 1 (5.3%) | 0 (0.0%) | 0 (0.0%) | 5 (15.2%) | 168 (41.7%) |
Wards | 138 (97.9%) | 16 (72.7%) | 0 (0.0%) | 18 (94.7%) | 16 (100.0%) | 19 (100.0%) | 28 (84.8%) | 235 (58.3%) |
Wound class | ||||||||
Clean | 47 (33.3%) | 0 (0.0%) | 153 (100.0%) | 0 (0.0%) | 11 (68.8%) | 19 (100.0%) | 24 (72.7%) | 254 (63.0%) |
Non-clean | 94 (66.7%) | 22 (100.0%) | 0 (0.0%) | 19 (100.0%) | 5 (31.3%) | 0 (0.0%) | 9 (27.3%) | 149 (37.0%) |
SSI type | ||||||||
Superficial | 115 (87.8%) | 6 (27.3%) | 117 (76.5%) | 9 (81.8%) | 8 (72.7%) | 9 (56.3%) | 20 (62.5%) | 284 (75.5%) |
Deep | 14 (10.7%) | 11 (50.0%) | 32 (20.9%) | 0 (0.0%) | 3 (27.3%) | 3 (18.8%) | 10 (31.3%) | 73 (19.4%) |
Organ/space | 2 (1.5%) | 5 (22.7%) | 4 (2.6%) | 2 (18.2%) | 0 (0.0%) | 4 (25.0%) | 2 (6.3%) | 19 (5.1%) |
Diagnosis time | ||||||||
Before discharge | 12 (9.7%) | 13 (76.5%) | 60 (40.5%) | 9 (52.9%) | 2 (12.5%) | 3 (25.0%) | 12 (40.0%) | 111 (30.5%) |
After discharge | 81 (65.3%) | 3 (17.6%) | 69 (46.6%) | 8 (47.1%) | 10 (62.5%) | 4 (33.3%) | 15 (50.0%) | 190 (52.2%) |
On readmission | 31 (25.0%) | 1 (5.9%) | 19 (12.8%) | 0 (0.0%) | 4 (25.0%) | 5 (41.7%) | 3 (10.0%) | 63 (17.3%) |
Hospital death | ||||||||
No | 101 (100.0%) | 11 (61.1%) | 116 (90.6%) | 15 (100.0%) | 13 (100.0%) | 14 (100.0%) | 29 (96.7%) | 299 (93.7%) |
Yes | 0 (0.0%) | 7 (38.9%) | 12 (9.4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.3%) | 20 (6.3%) |
Causative pathogens
CSEC (N = 160) | COLO (N = 29) | CBGB (N = 194) | CHOL (N = 28) | HER (N = 21) | KPRO (N = 22) | Others (N = 38) | Total (N = 492) | |
---|---|---|---|---|---|---|---|---|
All gram positive bacteria | 89 (55.6%) | 6 (20.7%) | 50 (25.8%) | 6 (21.4%) | 8 (38.1%) | 8 (36.4%) | 2 (5.3%) | 169 (34.3%) |
Staphylococcus aureus | 67 (41.9%) | 1 (3.4%) | 28 (14.4%) | 3 (10.7%) | 5 (23.8%) | 7 (31.8%) | 1 (2.6%) | 112 (22.8%) |
Enterococcus spp. | 10 (6.3%) | 5 (17.2%) | 8 (4.1%) | 2 (7.1%) | 3 (14.3%) | (0.0%) | 1 (2.6%) | 29 (5.9%) |
Coagulase negative staphylococci | 11 (5.7%) | 1 (4.5%) | 12 (2.4%) | |||||
Other gram positive | 12 (7.5%) | 3 (1.5%) | 1 (3.6%) | 16 (3.3%) | ||||
All gram negative bacteria | 71 (44.4%) | 23 (79.3%) | 142 (73.2%) | 17 (60.7%) | 13 (61.9%) | 14 (63.6%) | 36 (94.7%) | 316 (64.2%) |
Acinetobacter spp. | 1 (0.6%) | 1 (3.4%) | 4 (2.1%) | 1 (3.6%) | 1 (4.5%) | 4 (10.5%) | 12 (2.4%) | |
Pseudomonas aeruginosa | 19 (11.9%) | 6 (20.7%) | 52 (26.8%) | 2 (7.1%) | 5 (23.8%) | 7 (31.8%) | 8 (21.1%) | 99 (20.1%) |
Klebsiella spp. | 15 (9.4%) | 4 (13.8%) | 29 (14.9%) | 4 (14.3%) | 2 (9.5%) | 1 (4.5%) | 5 (13.2%) | 60 (12.2%) |
Enterobacter spp. | 8 (5.0%) | 2 (6.9%) | 18 (9.3%) | 2 (7.1%) | 1 (4.8%) | 0 | 7 (18.4%) | 38 (7.7%) |
Escherichia coli | 17 (10.6%) | 8 (27.6%) | 16 (8.2%) | 5 (17.9%) | 2 (9.5%) | 2 (9.1%) | 10 (26.3%) | 60 (12.2%) |
Serratia spp. | 1 (0.6%) | 13 (6.7%) | 1 (3.6%) | 15 (3.0%) | ||||
Proteus spp. | 7 (4.4%) | 3 (1.5%) | 3 (14.3%) | 13 (2.6%) | ||||
Other gram negative | 3 (1.9%) | 2 (6.9%) | 7 (3.6%) | 2 (7.1%) | 3 (13.6%) | 2 (5.3%) | 19 (3.9%) | |
Fungi | 2 (1.0%) | 5 (17.9%) | 7 (1.4%) |
Resistant pathogens
CSEC (N = 137) | COLO (N = 27) | CBGB (N = 155) | CHOL (N = 19) | HER (N = 18) | KPRO (N = 18) | Others (N = 36) | Total (N = 410) | |
---|---|---|---|---|---|---|---|---|
Tested pathogens | ||||||||
Staphylococcus aureus | 60 (89.6%) | 1 (100.0%) | 26 (92.9%) | 3 (100.0%) | 3 (60.0%) | 5 (71.4%) | 1 (100.0%) | 99 (88.4%) |
Enterococcus spp. | 9 (90.0%) | 2 (40.0%) | 7 (87.5%) | 1 (50.0%) | 3 (100.0%) | 1 (100.0%) | 23 (79.3%) | |
Klebsiella spp. (cephalosporins) | 15 (100.0%) | 4 (100.0%) | 24 (82.8%) | 3 (75.0%) | 2 (100.0%) | 1 (100.0%) | 3 (60.0%) | 52 (86.7%) |
Enterobacteriaceae | 35 (92.1%) | 7 (63.6%) | 37 (60.7%) | 8 (80.0%) | 4 (80.0%) | 3 (100.0%) | 16 (80.0%) | 110 (74.3%) |
Acinetobacter spp. | 1 (100.0%) | 1 (100.0%) | 4 (100.0%) | 1 (100.0%) | 1 (100.0%) | 4 (100.0%) | 12 (100.0%) | |
Pseudomonas aeruginosa | 18 (94.7%) | 6 (100.0%) | 51 (98.1%) | 2 (100.0%) | 5 (100.0%) | 6 (85.7%) | 8 (100.0%) | 96 (97.0%) |
Klebsiella spp. (at least 3 classes) | 10 (66.7%) | 4 (100.0%) | 24 (82.8%) | 4 (100.0%) | 2 (100.0%) | 1 (100.0%) | 4 (80.0%) | 49 (81.7%) |
Escherichia coli | 12 (70.6%) | 7 (87.5%) | 15 (93.8%) | 5 (100.0%) | 1 (50.0%) | 1 (50.0%) | 8 (80.0%) | 49 (81.7%) |
Resistance types | ||||||||
MRSA | 20 (33.3%) | 1 (100.0%) | 6 (23.1%) | 1 (33.3%) | 0 (0.0%) | 2 (40.0%) | 0 (0.0%) | 30 (30.3%) |
VRE | 0 (0.0%) | 1 (50.0%) | 1 (14.3%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 3 (13.0%) | |
CephR Klebsiella | 1 (6.7%) | 1 (25.0%) | 4 (16.7%) | 2 (66.7%) | 2 (100.0%) | 1 (100.0%) | 2 (66.7%) | 13 (25.0%) |
CRE | 1 (2.9%) | 2 (28.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (33.3%) | 2 (12.5%) | 6 (5.5%) |
MDR Acinetobacter | 0 (0.0%) | 1 (100.0%) | 2 (50.0%) | 1 (100.0%) | 1 (100.0%) | 2 (50.0%) | 7 (58.3%) | |
MDR Pseudomonas | 0 (0.0%) | 1 (16.7%) | 4 (7.8%) | 0 (0.0%) | 0 (0.0%) | 1 (16.7%) | 1 (12.5%) | 7 (7.3%) |
MDR Klebsiella | 0 (0.0%) | 1 (25.0%) | 3 (12.5%) | 1 (25.0%) | 2 (100.0%) | 1 (100.0%) | 2 (50.0%) | 10 (20.4%) |
MDR Escherichia coli | 2 (16.7%) | 2 (28.6%) | 0 (0.0%) | 2 (40.0%) | 0 (0.0%) | 0 (0.0%) | 2 (25.0%) | 8 (16.3%) |